Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 1
1978 1
1982 1
1983 2
1984 3
1985 1
1986 1
1987 2
1988 4
1989 1
1990 3
1991 3
1992 2
1993 1
1994 1
1995 2
1997 3
1998 2
1999 2
2000 1
2001 1
2003 2
2004 3
2005 1
2007 4
2008 2
2009 1
2010 6
2011 4
2012 5
2013 5
2014 3
2015 4
2016 4
2017 4
2018 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: The Psychology of Pseudoscience.
Blancke S, Edis T, Braeckman J, Hansson SO, Landrum AR, Shtulman A. Blancke S, et al. Among authors: braeckman j. Front Psychol. 2022 May 31;13:935645. doi: 10.3389/fpsyg.2022.935645. eCollection 2022. Front Psychol. 2022. PMID: 35712163 Free PMC article. No abstract available.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
Fatal attraction: the intuitive appeal of GMO opposition.
Blancke S, Van Breusegem F, De Jaeger G, Braeckman J, Van Montagu M. Blancke S, et al. Among authors: braeckman j. Trends Plant Sci. 2015 Jul;20(7):414-8. doi: 10.1016/j.tplants.2015.03.011. Epub 2015 Apr 10. Trends Plant Sci. 2015. PMID: 25868652 Review.
Cabazitaxel for the treatment of prostate cancer.
Michielsen DP, Braeckman JG, Denis L. Michielsen DP, et al. Among authors: braeckman jg. Expert Opin Pharmacother. 2011 Apr;12(6):977-82. doi: 10.1517/14656566.2011.567268. Epub 2011 Mar 15. Expert Opin Pharmacother. 2011. PMID: 21406025 Review.
Prognostic factors in prostate cancer.
Braeckman J, Michielsen D. Braeckman J, et al. Recent Results Cancer Res. 2007;175:25-32. doi: 10.1007/978-3-540-40901-4_3. Recent Results Cancer Res. 2007. PMID: 17432552 Review.
Urinary incontinence in patients with cystic fibrosis.
Reichman G, De Boe V, Braeckman J, Michielsen D. Reichman G, et al. Among authors: braeckman j. Scand J Urol. 2016;50(2):128-31. doi: 10.3109/21681805.2015.1096826. Epub 2015 Oct 19. Scand J Urol. 2016. PMID: 26479266
83 results